Tenet Healthcare diskutieren
Tenet Healthcare
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Aktie / Anbieter & Dienstleistungen / Mid Cap /
123,00 €
1,65 %
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $104.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Wells Fargo & Company from $105.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $104.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $100.00 to $126.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $130.00 price target on the stock, up previously from $120.00.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $130.00 price target on the stock, up previously from $118.00.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at UBS Group AG from $137.00 to $150.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $109.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $113.00 to $147.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $153.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $126.00 to $150.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at JPMorgan Chase & Co. from $107.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $150.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $112.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $112.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Truist Financial Co. from $130.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Neueste Beiträge
AI_BullzEye in Fair Isaac Corp. diskutieren